A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 2, 2006, Pages 313-320

  Emmanouil, Dimitris E ^a   Papadopoulou Daifoti, Z ^b   Hagihara, Philip T ^c   Quock, Daniel G ^c   Quock, Raymond M ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

5 Hydroxytryptamine; Anxiety; HPLC quantification of brain monoamines; Light dark exploration test; Mice; Nitrous oxide; Rats

Indexed keywords

1 METHYL 3 INDAZOLECARBOXYLIC ACID N TROPANYLAMIDE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; CINANSERIN; DOPAMINE; FLUOXETINE; NITROUS OXIDE; SEROTONIN; SODIUM CHLORIDE;

AMBIENT AIR; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; EXPLORATORY BEHAVIOR; EXPOSURE; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOTHALAMUS; LIGHT EXPOSURE; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTI-ANXIETY AGENTS; CINANSERIN; CORPUS STRIATUM; DOPAMINE; FLUOXETINE; FRONTAL LOBE; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; INDAZOLES; MALE; MICE; NITROUS OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT2; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TROPANES;

RODENTIA;

EID: 33746311597     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.05.016     Document Type: Article

References (64)

1. Abdul-Kareem H.S., Sharma R.P., and Drown D.B. Effects of repeated intermittent exposures to nitrous oxide on central neurotransmitters and hepatic methionine synthetase activity in CD-1 mice. Toxicol Ind Health 7 (1991) 97-108
2. Aghajanian G. Electrophysiology of serotonin receptor subtypes and signal transduction pathways. In: Bloom F., and Kupfer D. (Eds). Psychopharmacology: the fourth generation of progress (1995), Raven Press, New York 451-460
3. Buhot M. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7 (1997) 243-254
4. Chapman C.R., and Benedetti C. Nitrous oxide effects on cerebral evoked potential to pain: partial reversal with a narcotic antagonist. Anesthesiology 51 (1979) 135-138
5. Chaouloff F., Aguerre S., and Mormede P. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats. Neuropharmacology 37 (1998) 1159-1167
6. Connor T.J., Kelly J.P., and Leonard B.E. Forced swim test-induced neurochemical endocrine, and immune changes in the rat. Pharmacol Biochem Behav 58 (1997) 961-967
7. 3 receptor antagonists. Pharmacol Toxicol 70 (1992) 157-162
8. 3 receptors. Curr Drug Targets CNS Neurol Disord 3 (2004) 27-37
9. 3 receptor antagonist, RS-42358-197, in animal models of anxiety. Eur J Pharmacol 234 (1993) 91-99
10. Cransac H., Cottet-Emard J.M., Pequignot J.M., and Peyrin L. Monoamines (norepinephrine, dopamine, serotonin) in the rat medial vestibular nucleus: endogenous levels and turnover. J Neural Transm 103 (1996) 391-401
11. Czech D.A., and Quock R.M. Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker. Psychopharmacology 113 (1993) 211-216
12. Davis M. Are different parts of the extended amygdala involved in fear vs. anxiety. Biol Psychiatry 44 (1998) 1239-1247
13. 2 receptors, depression and anxiety. Pharmacol Biochem Behav 29 (1988) 819-820
14. Dorris R.L., and Truong V. Locomotor effects of nitrous oxide in mice: requirement of newly-synthesized and main intraneuronal storage pools of dopamine. J Pharm Pharmacol 45 (1993) 315-316
15. Emmanouil D.E., Johnson C.H., and Quock R.M. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors. Psychopharmacology 115 (1994) 167-172
16. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99 (1989) 248-251
17. 3 receptor. J Med Chem 30 (1987) 1535-1537
18. Gillman M.A., Kok L., and Lichtigfeld F.J. Paradoxical effect of naloxone on nitrous oxide analgesia in man. Eur J Pharmacol 61 (1980) 175-177
19. Glennon R.A., Dukat M., and Westkaemper R.B. Serotonin receptor subtypes and ligands. In: Bloom F.E., and Kupfer D. (Eds). Psychopharmacology: the fourth generation of progress (1995), Raven Press, New York
20. Gorman J.M., Hirschfeld R.M., and Ninan P.T. New developments in the neurobiological basis of anxiety disorders. Psychopharmacol Bull 36 Suppl 2 (2002) 49-67
21. Handley S.L. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66 (1995) 103-148
22. 3 antagonist-induced reductions in alcohol drinking. Neuropsychopharmacology 29 (2004) 1807-1813
23. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71 4 (2002(April)) 533-554
24. Hynes M.D., and Berkowitz B.A. Nitrous oxide stimulation of locomotor activity: evidence for an opiate-like behavioral effect. J Pharmacol Exp Ther 209 (1979) 304-308
25. Hynes M.D., and Berkowitz B.A. Catecholamine mechanisms in the stimulation of mouse locomotor activity by nitrous oxide and morphine. Eur J Pharmacol 90 1 (1983(May 20)) 109-114
26. Iversen S.D. 5-HT and anxiety. Neuropharmacology 23 (1984) 1553-1560
27. Jackson D.L., and Johnson B.S. Inhalational and enteral conscious sedation for the adult dental patient. Dent Clin North Am 46 (2002) 781-802
28. 3 receptors. Psychopharmacology 97 (1989) 489-495
29. 3 antagonists in two animal tests of anxiety. Neurosci Lett 32 (1988) S44
30. Jones B.J., Costall B., Domeney A.M., Kelly M.E., Naylor R.J., Oakley N.R., et al. The potential anxiolytic activity of GR38032F, a 5HT3-receptor antagonist. Br J Pharmacol 93 (1988) 985-993
31. 3A receptor subunit produces an anxiolytic phenotype in mice. Eur J Pharmacol 461 (2003) 19-25
32. Kofke W.A., Stiller R.L., and Rose M.E. Comparison of extracellular dopamine concentration in awake unstressed and postsurgical nitrous oxide sedated rats. J Neurosurg Anesthesiol 7 (1995) 280-283
33. Karuri A.R., Kugel G., Engelking L.R., and Kumar M.S. Alterations in catecholamine turnover in specific regions of the rat brain following acute exposure to nitrous oxide. Brain Res Bull 45 (1998) 557-561
34. 2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 17 (1993) 411-417
35. LeDoux J. Fear and the brain: where have we been, and where are we going?. Biol Psychiatry 44 (1998) 1229-1238
36. 2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test. Pharmacol Biochem Behav 68 (2001) 789-796
37. Mueller J.L., and Quock R.M. Contrasting influences of 5Hydroxytryptamine receptors in nitrous oxide antinociception in mice. Pharmacol Biochem Behav 41 (1992) 429-432
38. Murakawa M., Adachi T., Nakao S., Seo N., Shingu K., and Mori K. Activation of the cortical and medullary dopaminergic systems by nitrous oxide in rats: a possible neurochemical basis for psychotropic effects and postanesthetic nausea and vomiting. Anesth Analg 78 (1994) 376-381
39. 2 ligands on three mouse models of anxiety. Behav Brain Res 140 (2003) 203-214
40. 3 receptor antagonists and anxiety: a preclinical and clinical review. Eur Neuropsychopharmacol 10 (2000) 77-95
41. Papadopoulou-Daifoti Z., Antoniou K., Vamvakidis A., Kalliteraki I., and Varonos D.D. Neurochemical changes in dopamine and serotonin turnover rate in discrete regions of rat brain after the administration of glycinergic compounds. Acta Ther 21 (1995) 5-18
42. Paterson S.A., and Tahmassebi J.F. Paediatric dentistry in the new millennium: 3. Use of inhalation sedation in paediatric dentistry. Dent Update 30 358 (2003) 350-356
43. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24 (1986) 525-529
44. Pineyro G., and Blier P. Autoregulation of serotonin neurons: role in antidepresant drug action. Pharmacol Rev 51 (1999) 534-591
45. Quock R.M., Emmanouil D.E., Vaughn L.K., and Pruhs R.J. Benzodiazepine receptor mediation of behavioral effects of nitrous oxide in mice. Psychopharmacology 107 (1992) 310-314
46. Quock R.M., and Vaughn L.K. Nitrous oxide: mechanism of its analgesic action. Analgesia 1 (1995) 151-159
47. Quock R.M., Wojcechowskyj J.A., and Emmanouil D.E. Comparison of nitrous oxide, morphine and diazepam effects in the mouse staircase test. Psychopharmacology 92 (1987) 324-326
48. Quock R.M., Wetzel P.J., Maillefer R.H., Hodges B.H., Curtis B.A., and Czech D.A. Benzodiazepine receptor-mediated behavioral effects of nitrous oxide in the rat social interaction test. Pharmacol Biochem Behav 46 (1993) 161-165
49. Raheja R.K., Bharwani I., and Penetrante A.E. Efficacy of risperidone for behavioral disorders in the elderly: a clinical observation. J Geriatr Psychiatry Neurol 8 (1995) 159-161
50. Rainnie D. Serotonergic modulation of neurotransmission in the rat basolateral amygdala. J Neurophysiol 82 (1999) 69-85
51. Ripoll N., Nic Dhonnchadha B.A., Sebille V., Bourin M., and Hascoet M. The four-plates test-retest paradigm to discriminate anxiolytic effects. Psychopharmacology (Berl) 180 (2005) 73-83
52. 3 antagonists and benzodiazepines: their comparative behavioural pharmacology (1991), John Wiley and Sons Ltd, Chichester 365-376
53. Sharp T., Zetterstrom T., Series H.G., Carlsson A., Grahame-Smith D.G., and Ungerstedt U. HPLC-EC analysis of catechols and indoles in rat brain dialysates. Life Sci. 41 (1987) 869-872
54. Shannon N.J., Gunnet J.W., and Moore K.E. A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus. J Neurochem 47 (1986) 958-965
55. 3H]citalopram binding sites in the nonhuman primate brain. Ann NY Acad Sci 877 (1999) 700-702
56. Stutzmann G., McEwen B., and LeDoux J. Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone. J Neurosci 18 (1998) 9529-9538
57. Suzuki T., Koyama H., Sugimoto M., Uchida I., and Mashimo T. The diverse actions of volatile and gaseous anesthetics on human-cloned 5hydroxytryptamine3 receptors expressed in Xenopus oocytes. Anesthesiology 96 (2002) 699-704
58. Thorre K., Chaouloff F., Sarre S., Meensen R., Ebinger G., and Michotte Y. Differential effects of restraint stress on hippocampal 5-HT metabolism and extracellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res 772 (1997) 209-216
59. Turle N., Saget A., Zouani B., and Risso J.J. Neurochemical studies of narcosis: a comparison between the effects of nitrous oxide and hyperbaric nitrogen on the dopaminergic nigrostriatal pathway. Neurochem Res 23 (1998) 997-1003
60. 3 antagonists in laboratory animals. Neurosci Lett 29 (1987) S68
61. Wilde M.I., and Markham A. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications. Drugs 52 (1996) 773-794
62. Yamakura T., and Harris R.A. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Anesthesiology 93 (2000) 1095-1101
63. Yang J.C., Clark W.C., and Ngai S.H. Antagonism of nitrous oxide analgesia by naloxone in man. Anesthesiology 52 (1980) 414-417
64. Zorumski C.F., and Isenberg K.E. Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry. Am J Psychiatry 148 (1991) 162-173